Sources
Loading...
Additional media
Loading...
DeepNewz, mobile.
People-sourced. AI-powered. Unbiased News.
Clario, a software provider for drugmakers, has confidentially filed for an initial public offering (IPO) in the United States, targeting a valuation of more than $10 billion, Bloomberg reports. The company, which was named the top Biotechnology Company of 2024 by The Healthcare Technology Report, helps drugmakers advance treatments through clinical trials. Clario is backed by Nordic Capital and Astorg and has hired JPMorgan, Morgan Stanley, Jefferies, and UBS to assist with the listing.
Clario files confidentially for US IPO, Bloomberg reports https://t.co/RUi89AN5LP https://t.co/gmk0Wmq8KB
pharma tech scoop: Clario has filed confidentially for an IPO that could value it at more than $10 billion, per sources. The co., backed by Nordic Capital and Astorg, has hired JPM, MS, Jefferies and UBS to help with a listing. story w/ @rngould @DNair5 https://t.co/N7AnLhuLL7
Clario files confidentially for US IPO, Bloomberg reports https://t.co/hk7k2ezT70 https://t.co/7C7ir06BvF